Infection and ImmunityImmunologyPeer-reviewed journal article
Characterizing PET CT patterns and bacterial dissemination features of tuberculosis relapse in the macaque model
Pauline A MaielloiD, Collin R. DiedrichiD, Tara W. Rutledge, Mark RodgersiD, Kara B. Kracinovsky, Henry Jacob BorishiD, Alexander G. White, Forrest F. HopkinsiD, Michael C. ChaoiD, Edwin C. KleiniD, Sarah M. FortuneiD, JoAnne L. FlynniD, Philana Ling LiniD
Abstract
Tuberculosis (TB) relapse after appropriate drug treatment is poorly understood but critical to developing shorter treatment regimens. Using a cynomolgus macaque model of human TB, macaques with active TB disease were treated with a short course of isoniazid and rifampin and subsequently infected with SIV. Serial clinical, microbiologic, immunologic and position emission and computed tomography (PET CT) assessments were performed to identify risk factors of relapse. Of the 12 animals, eight developed radiologically defined relapse including four that had clinical and/or microbiologic signs. Greater gross pathology and bacterial burden were observed in relapse animals. PET CT characteristics before, during, and at the end of treatment were similar amongst relapse and non-relapse animals. We show that complete sterilization or very low Mtb burden is protective against SIV-induced TB relapse but cannot be predicted by PET CT. Using bar-coded M. tuberculosis, we found that Mtb dissemination during relapse originated from both lung and thoracic lymph nodes, underscoring the importance of lymph nodes as a reservoir. By matching bar-coded Mtb and serial PET CT, we also demonstrate that not every site of persistent Mtb growth after drug treatment is capable of dissemination and relapse, underscoring the complex nature of drug treatment and relapse.
- organism: non-human primate
- assay: imaging
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 4
- FWCI
- 3.06
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cure-screening predicts mechanism of post-antibiotic relapse in Tuberculosis
Christian T. Michael, Maral Budak, … Denise E. Kirschner·bioRxiv·Apr 27, 2026
- Antibiotic treatment does not abrogate protection against Mycobacterium tuberculosis reinfection
S. K. Ganchua, P. Maiello, … J. L. Flynn·bioRxiv·Dec 19, 2023
- MIP3α-RelMtb intranasal DNA vaccination induces reactive T-cell infiltration into the lungs in mice and macaques
James T. Gordy, Jean J. Zheng, … Richard B. Markham·VaccinePeer-reviewed·Jul 16, 2025
- Interstitial macrophages prevent tuberculosis relapse by restricting Mycobacterium tuberculosis immune evasion
Valérie Vinette, Anthony Castro, … Sabine Ehrt·The Journal of ImmunologyPeer-reviewed·Jul 28, 2026
- Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques
J. L. Flynn, A. M. Cadena, … S. M. Fortune·bioRxiv·Aug 29, 2018
- Antibiotic treatment shapes antigen presentation during chronic TB infection, offering novel targets for therapeutic vaccination
Y.-M. Chuang, N. K. Dutta, … P. C. Karakousis·bioRxiv·May 15, 2019